Literature DB >> 8261023

Phosphorylation of tau by cyclic-AMP-dependent protein kinase.

J Robertson1, T L Loviny, M Goedert, R Jakes, K J Murray, B H Anderton, D P Hanger.   

Abstract

Alzheimer's disease paired helical filaments contain abnormally phosphorylated tau (PHF-tau) which has reduced electrophoretic mobility on sodium dodecyl sulphate polyacrylamide electrophoresis. We have investigated the effects of cyclic-AMP-dependent protein kinase (PKA) on recombinant human tau isoforms and two recombinant tau fragments. PKA phosphorylated tau and reduced its electrophoretic mobility, phosphorylation towards the C-terminus of tau having a major influence on this property. Substitution of serine396 (phosphorylated in PHF-tau) or serine416 (phosphorylated by calcium/calmodulin kinase II) by alanine demonstrated that these are not major sites for PKA phosphorylation. Although the phosphorylated forms of tau generated by PKA are not identical to those of PHF-tau, PKA may be involved in the generation of PHF-tau in Alzheimer's disease via phosphorylation of additional, as yet unidentified, sites on tau.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8261023     DOI: 10.1159/000107331

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  9 in total

1.  Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice.

Authors:  Hien T Tran; Laura Sanchez; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

2.  Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells.

Authors:  Qing-Guo Ren; Yan-Juan Wang; Wei-Gang Gong; Qi-Da Zhou; Lin Xu; Zhi-Jun Zhang
Journal:  J Mol Neurosci       Date:  2015-02-17       Impact factor: 3.444

Review 3.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

4.  Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A.

Authors:  Xin-An Liu; Ling-Qiang Zhu; Qi Zhang; Hai-Rong Shi; Shao-Hui Wang; Qun Wang; Jian-Zhi Wang
Journal:  Neurochem Res       Date:  2008-03-13       Impact factor: 3.996

5.  Global analysis of phosphorylation of tau by the checkpoint kinases Chk1 and Chk2 in vitro.

Authors:  Jhoana Mendoza; Michiko Sekiya; Taizo Taniguchi; Koichi M Iijima; Rong Wang; Kanae Ando
Journal:  J Proteome Res       Date:  2013-04-26       Impact factor: 4.466

6.  Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage.

Authors:  Zhihou Liang; Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures.

Authors:  D R Davis; J P Brion; A M Couck; J M Gallo; D P Hanger; K Ladhani; C Lewis; C C Miller; T Rupniak; C Smith
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

8.  Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau.

Authors:  Xue Zhang; Yun-wu Zhang; Shijie Liu; Ayelen Bulloj; Gary G Tong; Zhuohua Zhang; Francesca-Fang Liao; Huaxi Xu
Journal:  Mol Neurodegener       Date:  2006-07-31       Impact factor: 14.195

9.  Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.

Authors:  Shreyasi Chatterjee; Tzu-Kang Sang; George M Lawless; George R Jackson
Journal:  Hum Mol Genet       Date:  2008-10-17       Impact factor: 6.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.